81/113US=84-A / Biol/Mol
Schlingensiepen KH, Jachimczak P, Fischer-Blass B, Fischer D, Specht H, schmaus S, Schlingensiepen R. Development of inhibitors of transforming growth factor-B signaling for therapy: targeted downregulation of TGF-B2 with AP 12009 in tumor therapy. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 635-51. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

OLIGODEOXINUCLEOTIDOS ANTISENSE; CANCER; GLIOMA MALIGNO; TGF-B; USO TERAPEUTICO

82/113US=84-A / Biol/Mol
Naumann U, Weller M. Development of inhibitors of transforming growth factor-B signaling for therapy: modulating TGF-B receptor signaling: a novel approach of cancer therapy. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 653-69. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGF-B; TGF-B RECEPTORES; MOLECULAS PEQUENAS; DOMINANTE NEGATIVO; RECEPTOR SOLUVEL

83/113US=84-A / Biol/Mol
De Crescenzo G, Chao H, Zwaagstra J, Durocher Y, O'Connor-McCourt MD. Development of inhibitors of transforming growth factor-B signaling for therapy: engineering TGB-B traps: artificially dimerized receptor ectodomains as high-affinity blockers of TGF-B action. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 671-84. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

FACTOR DE CRESCIMENTO TRANSFORMANTE-B; ANTAGONISTA; BETAGLICAM; ARMADILHA LIGANTE; RECEPTOR ECTODOMINIO

84/113US=84-A / Biol/Mol
Ling LE, Singh J, Chuaqui CE, Boriack-Sjodin PA, Corbley MJ, Lepage DJ, Silverio EL, Sun L, Papadatos JL, Shan F, Pontz T, Kam Cheung H, Zhang X, Arduini RM, Mead JN, Newman MN, Bowes S, Josiah S, Lee WC. Development of inhibitors of transforming growth factor-B signaling for therapy: the use of virtual screening in ALK5 kinase inhibitor discovery and validation of orally active ALK5 kinase inhibitors in oncology. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 685-96. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

VIRTUAL; FARMACOFORO; INIBIDOR DE CINASE; ALK5; TGF-B RECEPTOR TIPO I; CRISTALOGRAFIA DE RAIOS X; TGF-B

85/113US=84-A / Biol/Mol
Suzuki E, Albelda SM. Development of inhibitors of transforming growth factor-B signaling for therapy: soluble type II transforming growth factor-B receptor inhibits tumorigenesis by augmenting host ntitumor immunity. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 697-706. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGF-B; IMUNIDADE ANTITUMORAL; MESOTELIOMA MALIGNO; SOLUVEL DO TIPO II DO RECEPTOR DE TGF-B

86/113US=84-A / Biol/Mol
Lacher MD, Korn WM, Akhurst RJ. Development of inhibitors of transforming growth factor-B signaling for therapy: reversal of EMT by small-molecule inibitors of TGF-B type I and II receptors: implications for carcinoma treatment. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 707-22. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGF-B RECEPTORES; PEQUENAS MOLECULAS INIBIDORES; EPITELIAL PARA MESEACHYMAL TRANSICAO; EMT; METASTASE; VIRUS COXSACKIE E RECEPTOR ADENOVIRUS; TERAPIA DO CANCRO ADENOVIRAL

87/113US=84-A / Biol/Mol
Bandyópadhyay A, Sun L. Development of inhibitors of transforming growth factor-B signaling for therapy: soluble TGF-B type III receptor suppresses malignant progression of human cancer cells. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 723-35. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

ANGIOGENESE; METALOPROTEINASE DE MATRIZ-9; METASTASE PULMONAR; METASTASE OSSEA; BETAGLICAM SOLUVEL; TGF-B; TGF-B TIPO DE INIBIDORES DO RECEPTOR III; TUMORIGENESE

88/113US=84-A / Biol/Mol
Hoffmann FM, Cui Q, Lim SK, Zhao BM. Development of inhibitors of transforming growth factor-B signaling for therapy: targeting smad-dependent TGF-B signaling with peptide aptamers. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 737-56. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

APTAMEROS PEPTIDEO; MOTIVO DE PROTEINA; PROTEINA ANDAIME; SMAD; TGF-B INIBIDORES

89/113US=84-A / Biol/Mol
Hsu FJ, Teicher BA, McPherson JM. Development of inhibitors of transforming growth factor-B signaling for therapy: rationale for anti-TGF-B antibody therapy in oncology. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 757-74. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

FACTOR DE CRESCIMENTO TRANSFORMANTE-B; IMUNOSSUPRESSAO; METASTASE OSSEA; CARCINOMA DE CELULAS RENAIS; MELANOMA; CANCER DE MAMA; HORMONAL DO CANCER DA PROSTATA REFRATARIOS; CANCER DE PANCREAS; MIELOMA MULTIPLO; LINFOMA DE NAO-HOGGKIN; BIOMARCADORES

90/113US=84-A / Biol/Mol
Kohn EA, Tang B. Transformig growth factor-B in developing and advanced cancers: tumor suppresor and pro-progression roles for TGF-B in breast cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 285-307. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGF-B; CANCER DE MAMA; TUMOR SUPRESSOR; SUPRESSOR DE TUMOR; PROMOTOR DE TUMOR; PARACRINA

91/113US=111 / Câncer
Zhu B, Kyprianou N. Transforming growth factor-beta and cancer. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 257-71. ISBN 978-0-470-01852-1.

CANCER; FATOR TRANSFORMADOR DE CRESCIMENTO BETA; FAMILIA TGF-BETA

92/113US=16 / Urologia
Lee C, Shah A, Liu V, Park I, Wong L, Huang X, Huang L, Fermin T, Jang T, Kundu S, Zhou V, Zhang Q, Smith N. Biology and imaging: role of transformig growth factor-B in immunotherapy of prostate cancer. In: Chung LWK, Isaacs WB, Simons JW. Prostate cancer: biology, genetics, and the new therapeutics. 2ª ed. New Jersey: Humana Press, 2007. p. 165-74. (Contemporary Cancer Research) ISBN 978-1-58829-696-2.

BIOLOGIA; IMAGEM; FATOR DE TRANSFORMACAO DO CRESCIMENTO BETA; IMUNOTERAPIA; CANCER DE PROSTATA; TRANSFERENCIA ADOTIVA; CELULAS T CITOLITICAS; IMUNOTERAPIA; SINALIZACAO TGF-B

93/113US=23 / Clín/Médica
Chiamolera M, Silva FP. Aspectos imunológicos: reconhecimento e ataque ao antígeno: citocinas e quimiocinas. In: Silva FP, Velasco IT. Sepse. Barueri: Manole, 2007. p. 200-8. ISBN 85-2042558-5.

CITOCINAS; QUIMIOCINAS; CITOCINAS PRO-INFLAMATORIAS; CITOCINAS ANTIINFLAMATORIAS; TGF-BETA; VIAS DE SINALIZACAO

94/113US=4 / Odontologia
Shillingburg HT Jr, Hobo S, Whitsett LD, Jacobi R, Brackett SE. Técnica para a obtenção da trajetória gerada funcionalmente. In: ___. Fundamentos de prótese fixa. 4ªed. São Paulo: Quintessence, 2007. p. 291-8. ISBN 85-8742575-1.

TRAJETORIA GERADA FUNCIONALMENTE; TGF

95/113US=47 / Clín/Medica
Crivello A, Giacalone A, Vaglica M, Scola L, Forte GI, Macaluso MC, Raimondi C, Di Noto L, Bongiovanni A, Accardo A, Candore G, Palmeira S. Regulatory cytokine gene polymorphism and risk of colorectal carcinoma. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 98-103. ISBN 978-1-57331-699-5.

RISCO DE CARCINOMA COLORRETAL; CANCER COLORRETAL; POLIMORFISMO DO GENE; TGF-B1; IL-10

96/113US=47 / Clín/Medica
Buck MB, Knabbe C. TGF-Beta signaling in breast cancer. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 119-26. ISBN 978-1-57331-699-5.

ANTIESTROGENEO; TGF-BETA; CANCER DE MAMA; INIBICAO DO CRESCIMENTO; METASTASE

97/113US=61 / Câncer
Pinkas J, Teicher BA. The role of hormones, growth factors, and oncogenes: role of TGF-b in tumor progression and metastasis. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 469-89. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

FATOR DE CRESCIMENTO TRANSFORMANTE-B; RECEPTOR DO FATOR DE CRESCIMENTO TRANSFORMANTE-B; SMAD; OSTEOCLASTOS; FIBROSE

98/113US=8 / Ortopedia
Iannetta O. Matriz mesenquimal óssea e etiopatogenia da osteoporose no climatério. In: ___. Osteoporose: uma ex-enfermidade silenciosa. Ribeirão Preto: Tecmedd, 2006. p. 62-95. ISBN 85-99276-03-4.

OSTEOPOROSE. ETIOPATOGENIA; MATRIZ MESENQUIMAL OSSEA; CLIMATERIO; FRATURA; TECIDOS CONECTIVOS; VITAMINA D; PTH; CALCITONINA; ESTROGENIO; PROGESTERONA; PROGESTAGENIOS; GLICOCORTICOIDES; CIGARRO; ATIVIDADE FISICA; REMODELACAO OSSEA; OSTEOBLASTOS; OSTEOCLASTOS; FORMACAO OSSEA; TGF; INTERLEUCINA-6; INTERLEUCINA-11

99/113US=610 / Tese/FAP
Leite CAVG. Papel da sepse na iniciação e promoção de câncer colorretal associado à colite. [Role of sepsis in initiation and promotion of colitis-associated colorectal cancer]. São Paulo, 2016. 140 p. Tese(Doutorado/Dinter)-Programa de Pós Graduação Interinstitucional em Oncologia da Fundação Antônio Prudente/Escola Cearense de Oncologia.

Disponível em: http://accamargo.phlnet.com.br/Doutorado/2016/CaioAbner/CaioAbner.pdf

Curriculum Lattes

NEOPLASIAS COLORRETAIS; SEPSE; LINFOCITOS T REGULADORES; MACROFAGOS; COLITE; MODELOS ANIMAIS

100/113US=264 / Tese/FAP
Barreto BD. Validação de classificadores moleculares preditores de resposta à quimioterapia combinada com radioterapia em carcinoma epidermóide de laringe e hipofaringe localmente avançado. [Validation of molecular classifiers for chemoradiotherapy response prediction of locally advanced larynx and hypopharynx tumors]. São Paulo, 2009. 154 p. Tese(Doutorado)-Fundação Antônio Prudente.

Disponível em: http://accamargo.phlnet.com.br/Doutorado/2009/BBarreto/BBarreto.pdf

Curriculum Lattes

ESTUDOS DE VALIDACAO COMO ASSUNTO; PERFIL DA EXPRESSAO GENICA; MARCADORES BIOLOGICOS; CANCER DE CABECA E PESCOCO; CARCINOMA EPIDERMOIDE; TGF-ALFA; QUIMIOTERAPIA; RADIOTERAPIA; VALIDACAO INDEPENDENTE; CLASSIFICADOR MOLECULAR; PREDITOR DE RESPOSTA

Primeira | Anterior | Próxima | Última